Kallikrein
Kallikrein(激肽释放酶)
Kallikrein 相关产品(26)
- GC71069Kallikrein 5-IN-2CAS: 2361160-57-6纯度: >98.00%
Kallikrein 5-IN-2(化合物21)是一种选择性Kallikrein KLK5抑制剂(pIC50=7.1)。
- GC71219Plasma kallikrein-IN-4CAS: 1357954-34-7纯度: >98.00%
Plasma kallikrein-IN-4（实施例153）是一种血浆激肽释放酶抑制剂，对人血浆激肽放酶的IC50为0.016μM。
- GC72335LanadelumabCAS: 1426055-14-2纯度: >99.00%
Lanadelumab（SHP643）是一种针对血浆激肽释放酶（pKal）的人IgG1单克隆抗体，Ki值为0.12 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC71069 | Kallikrein 5-IN-2 | 2361160-57-6 | >98.00% | |
Kallikrein 5-IN-2(化合物21)是一种选择性Kallikrein KLK5抑制剂(pIC50=7.1)。 | ||||
| GC71219 | Plasma kallikrein-IN-4 | 1357954-34-7 | >98.00% | |
Plasma kallikrein-IN-4（实施例153）是一种血浆激肽释放酶抑制剂，对人血浆激肽放酶的IC50为0.016μM。 | ||||
| GC72335 | Lanadelumab | 1426055-14-2 | >99.00% | |
Lanadelumab（SHP643）是一种针对血浆激肽释放酶（pKal）的人IgG1单克隆抗体，Ki值为0.12 nM。 | ||||
| GC72812 | Ecallantide TFA | - | >97.00% | |
Ecallantide TFA是一种特异性重组血浆激肽释放酶抑制剂。 | ||||
| GP21837 | KLK1 Human | - | - | |
Kallikrein-1 Human Recombinant | ||||
| GP21838 | KLK1 Human, His | - | - | |
Kallikrein-1 Human Recombinant, His Tag | ||||
| GP21839 | KLK2 Human | - | - | |
Kallikrein-2 Human Recombinant | ||||
| GP21840 | KLK2 Human, sf9 | - | - | |
Kallikrein-2 Human Recombinant, sf9 | ||||
| GP21841 | KLK3 | - | - | |
Kallikrein-3 Human Recombinant | ||||
| GP21842 | KLK3 Human | - | - | |
Kallikrein-3 Human | ||||
| GP21843 | KLK5 Human | - | - | |
Kallikrein-5 Human Recombinant | ||||
| GP21844 | KLK5 Human, Sf9 | - | - | |
Kallikrein-5 Human Recombinant, Sf9 | ||||
| GP21845 | KLK7 Human | - | - | |
Kallikrein-7 Human Recombinant | ||||
| GP21846 | KLK7 Human, sf9 | - | - | |
Kallikrein-7 Human Recombinant, sf9 | ||||
| GP21847 | KLK8 Mouse | - | - | |
Kallikrein-8 Mouse Recombinant | ||||
| GP21848 | KLK10 Human | - | - | |
Kallikrein-10 Human Recombinant | ||||
| GP21849 | KLK10 Human, Sf9 | - | - | |
Kallikrein-10 Human Recombinant, Sf9 | ||||
| GP21850 | KLK11 Human | - | - | |
Kallikrein-11 Human Recombinant | ||||
| GP21851 | KLK11 Human, Sf9 | - | - | |
Kallikrein-11, 4 Human Recombinant, Sf9 | ||||
| GP21852 | KLK13 Human | - | - | |
Kallikrein-13 Human Recombinant | ||||
| GP21853 | KLK13 Human, sf9 | - | - | |
Kallikrein-13 Human Recombinant, sf9 | ||||
| GP21854 | KLK15 Human | - | - | |
Kallikrein-15 Human Recombinant | ||||
| GP21855 | KLK15 Human, sf9 | - | - | |
Kallikrein-15 Human Recombinant, sf9 | ||||
| GP26161 | KLK3 Protein | - | - | |
Kallikrein-3 Human Recombinant produced in E | ||||